BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16555864)

  • 1. The effects of HMG-CoA reductase inhibitors on endothelial function.
    Tesfamariam B
    Am J Cardiovasc Drugs; 2006; 6(2):115-20. PubMed ID: 16555864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
    Rosenson RS
    Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidative effects of statins.
    Adam O; Laufs U
    Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium.
    Chłopicki S; Gryglewski RJ
    Pharmacol Rep; 2005; 57 Suppl():86-96. PubMed ID: 16415489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of statin use on endothelial function: from bench to clinics.
    Martínez-González J; Badimon L
    Curr Pharm Des; 2007; 13(17):1771-86. PubMed ID: 17584107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
    Laufs U
    Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of statins on endothelium and signaling mechanisms.
    Endres M; Laufs U
    Stroke; 2004 Nov; 35(11 Suppl 1):2708-11. PubMed ID: 15375300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
    Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
    Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
    Mason RP; Walter MF; Jacob RF
    Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho GTPases, statins, and nitric oxide.
    Rikitake Y; Liao JK
    Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and ischaemia reperfusion injury: a molecular biological review.
    Abdul Rahman MN; Chetter IC
    Curr Vasc Pharmacol; 2010 Nov; 8(6):831-5. PubMed ID: 19485917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-dependent effects of statins.
    Wolfrum S; Jensen KS; Liao JK
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):729-36. PubMed ID: 12615672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of statins.
    Liao JK; Laufs U
    Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Statins: possibly more than just lowering of the lipid level].
    Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):316-21. PubMed ID: 10707742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitavastatin, an HMG-CoA reductase inhibitor, ameliorates endothelial function in chronic smokers.
    Yoshida O; Kondo T; Kureishi-Bando Y; Sugiura T; Maeda K; Okumura K; Murohara T
    Circ J; 2010 Jan; 74(1):195-202. PubMed ID: 19926918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do HMG-CoA reductase inhibitors prevent stroke?
    Bedi A; Flaker GC
    Am J Cardiovasc Drugs; 2002; 2(1):7-14. PubMed ID: 14727994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HMG-CoA reductase inhibitor and risk of stroke].
    Endres M; Laufs U
    Nervenarzt; 1998 Aug; 69(8):717-21. PubMed ID: 9757426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.